Recommended Workup for Lymphadenopathy
The recommended workup for lymphadenopathy should include a risk-stratified approach starting with thorough history and physical examination, basic laboratory tests (CBC with differential, ESR, LDH, liver/renal function, HIV testing), ultrasound as first-line imaging, and proceeding to tissue sampling (FNAC, core biopsy, or excisional biopsy) for persistent or concerning lymphadenopathy. 1
Initial Assessment
Risk Factors for Malignancy
- Age >40 years
- Male sex
- White race
- Supraclavicular location
- Systemic symptoms (fever, night sweats, weight loss)
- Duration ≥2 weeks or uncertain duration
- Fixed to adjacent tissues
- Firm consistency
- Size >1.5 cm
- Ulceration of overlying skin 1, 2
Physical Examination
- Document location and characteristics of lymphadenopathy
- Note that palpable supraclavicular, popliteal, and iliac nodes are always abnormal
- Epitrochlear nodes >5 mm are abnormal
- Evaluate for signs of infection (warmth, erythema, tenderness) 1
Diagnostic Algorithm
Step 1: Classify as Localized or Generalized
- Localized: Single region involved
- Generalized: Two or more regions involved (suggests systemic disease) 2, 3
Step 2: Laboratory Testing
- Complete blood count with differential
- Erythrocyte sedimentation rate (ESR)
- Serum lactate dehydrogenase (LDH)
- Liver and renal function tests
- Hepatitis B and C testing
- HIV testing (especially in high-risk patients) 1
Step 3: Imaging
- Ultrasound as first-line imaging modality
- Assess size and morphology
- Evaluate presence/absence of hilum
- Document vascularity patterns
- Look for extracapsular spread 1
- Advanced imaging (CT or PET-CT) when:
- Malignancy is suspected
- Need to evaluate extent of disease
- Need to assess deep cervical nodes
- Need to evaluate adjacent structures 1
Step 4: Tissue Sampling (for persistent lymphadenopathy >3 weeks)
- Fine-needle aspiration cytology (FNAC)
- Core needle biopsy
- Higher diagnostic yield than FNAC
- Preserves tissue architecture
- Allows for additional studies (flow cytometry, molecular testing) 1
- Excisional biopsy (gold standard)
- Indicated when FNAC/core biopsy is non-diagnostic
- Necessary when lymphoma is strongly suspected
- Required for complete architectural assessment 1
Special Considerations
For Suspected Infection
- Antibiotics should only be prescribed with evidence of bacterial infection
- Reassess within 2 weeks of treatment
- Further workup for malignancy if mass hasn't completely resolved 1
For Suspected Hematologic Malignancy
- Bone marrow aspiration and biopsy when:
- Hematologic malignancy is suspected
- Unexplained cytopenia is present
- Abnormal cells seen on peripheral blood smear 1
For HIV-Positive Patients
- More thorough evaluation for opportunistic infections
- Higher risk for non-Hodgkin lymphoma
- Consider mycobacterial infections 1
For Suspected HHV-8 Associated Conditions
Common Pitfalls to Avoid
Delayed Diagnosis: Do not use empiric antibiotics without clear evidence of infection as this may delay diagnosis of malignancy 1
Inadequate Follow-up: Even if infectious lymphadenopathy resolves, patients should be reassessed in 2-4 weeks 1
Insufficient Sampling: For suspected lymphoma, excisional biopsy is preferred over FNAC to preserve architecture 1, 3
Overlooking Systemic Disease: For generalized lymphadenopathy, evaluate for underlying systemic conditions including autoimmune disorders, infections, and malignancies 2, 3
Misinterpreting Imaging: In HIV-positive patients, non-malignant causes of lymphadenopathy are more common with higher viral loads and lower CD4+ T-cell counts 5